US Only: Biosimilars have the potential to generate savings for patients and the US healthcare system. Recently, Len Arsenault, @DrSameerAwsare and @christinsimmon discussed how stakeholders can increase uptake and continue #PioneeringAccessForPatients. https://bddy.me/3zgdhKM
.@AccessibleMeds, which represents the generics industry, rightly observes that the generic supply chain has "performed exceptionally well since the onset of the COVID-19 pandemic." https://twitter.com/AccessibleMeds/status/1402325506012352516
Khatereh Calleja (@HSCA) leads a discussion with Bob Van Heuvelen, Steven Lucio & Christine Simmon on Value, Quality and Affordability in Pharmaceuticals when buying American during our #2021 National Pharmacy Forum!